T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Neogen
NEOG
$2.6B
| $968K | ﹤0.01% |
40,163
+759
| +2% | +$20.4K |
|
1902
Upbound Group
UPBD
$1.14B
| $968K | ﹤0.01% |
49,777
+39
| +0.1% | +$971 |
|
1903
InterDigital
IDCC
$8.91B
| $967K | ﹤0.01% |
15,909
+214
| +1% | +$13.1K |
|
|
AIMC
1904
DELISTED
Altra Industrial Motion Corp
AIMC
| $967K | ﹤0.01% |
27,424
+1,067
| +4% | +$39.7K |
|
1905
Moelis & Co
MC
$5.11B
| $966K | ﹤0.01% |
24,553
+1,244
| +5% | +$54.3K |
|
1906
WisdomTree US MidCap Fund
EZM
$963M
| $962K | ﹤0.01% |
20,929
| – | – |
|
|
CALY
1907
Callaway Golf Company
CALY
$2.98B
| $962K | ﹤0.01% |
47,150
+3,019
| +7% | +$64.9K |
|
1908
Fortis
FTS
$28.8B
| $960K | ﹤0.01% |
20,348
+16
| +0.1% | +$785 |
|
|
BNR
1909
Burning Rock Biotech
BNR
$98.1M
| $959K | ﹤0.01% |
32,955
-2,181
| -6% | -$97.4K |
|
1910
Newmark Group
NMRK
$2.74B
| $958K | ﹤0.01% |
99,081
+989
| +1% | +$11.4K |
|
1911
Cerus
CERS
$572M
| $957K | ﹤0.01% |
180,814
-44
| -0% | -$220 |
|
|
CVSA
1912
Covista Inc
CVSA
$4.48B
| $956K | ﹤0.01% |
26,581
-2,733
| -9% | -$86.1K |
|
1913
Rambus
RMBS
$10.9B
| $954K | ﹤0.01% |
44,396
+808
| +2% | +$20K |
|
1914
Chefs' Warehouse
CHEF
$4.64B
| $951K | ﹤0.01% |
24,455
+4,809
| +24% | +$169K |
|
1915
Mercury Insurance
MCY
$5.82B
| $947K | ﹤0.01% |
21,382
+1,029
| +5% | +$50.9K |
|
1916
Independent Bank Corp
IBCP
$853M
| $943K | ﹤0.01% |
48,891
+106
| +0.2% | +$2.1K |
|
1917
Eagle Bancorp
EGBN
$883M
| $942K | ﹤0.01% |
19,864
+230
| +1% | +$11.6K |
|
|
SFIX
1918
Stitch Fix
SFIX
$472M
| $932K | ﹤0.01% |
188,680
+18,000
| +11% | +$151K |
|
1919
BGC Group
BGC
$5.23B
| $931K | ﹤0.01% |
276,191
-7,004
| -2% | -$24.4K |
|
1920
Trustmark
TRMK
$2.82B
| $930K | ﹤0.01% |
31,861
+410
| +1% | +$11.9K |
|
|
MAXR
1921
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $928K | ﹤0.01% |
35,586
+3,334
| +10% | +$104K |
|
|
RPT
1922
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $927K | ﹤0.01% |
94,254
-25,764
| -21% | -$313K |
|
1923
Strategy Inc
MSTR
$36.3B
| $926K | ﹤0.01% |
56,380
+1,940
| +4% | +$56.1K |
|
1924
Northwest Natural Holdings
NWN
$2.14B
| $926K | ﹤0.01% |
17,444
+584
| +3% | +$30.1K |
|
1925
S&T Bancorp
STBA
$1.81B
| $924K | ﹤0.01% |
33,697
-7,118
| -17% | -$202K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.